Summary Company Announcement Date: September 06, 2023 FDA Publish Date: September 06, 2023 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential Foodborne Illness Company Name: Life Raft Treats Brand Name: Brand Name(s) Life Raft Treats Product Description: Product Description Ice Cream Products Company Announcement Angel [email protected] Kelen [email protected] Kerry [email protected] NORTH…
OBC Group Corp Recalls Nuez de la India Seeds and Capsules Products Due to Possible Health Risks
Summary Company Announcement Date: September 06, 2023 FDA Publish Date: September 06, 2023 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Possible Health Risk-Contain cardiac glycosides Company Name: OBC Group Corp Brand Name: Brand Name(s) NUT DIET MAX Product Description: Product Description Nuez de la India Seeds and Capsules Company Announcement OBC…
OBC Group Corp Retira Del Mercado Productos De Semillas Y Cápsulas De Nuez De La India Debido A Posibles Riesgos Para La Salud
Summary Company Announcement Date: September 06, 2023 FDA Publish Date: September 06, 2023 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Possible Health Risk-Contain cardiac glycosides Company Name: OBC Group Corp. Brand Name: Brand Name(s) NUT DIET MAX Product Description: Product Description Nuez de la India Seeds and Capsules Company Announcement OBC…
UPDATE: Risk of Device Failures for Getinge’s Maquet/Datascope Cardiosave Intra-Aortic Balloon Pump (IABP) – Letter to Health Care Providers
August 31, 2023 The U.S. Food and Drug Administration (FDA) is providing an update about device failures for Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices. The FDA is issuing this letter to help ensure health care providers are aware of the latest recalls and recommendations to users. Since June 2023, Getinge/Maquet/Datascope initiated…
Colorado Man Sentenced To 24 Months for Drug Smuggling and Money Laundering Offenses
Department of JusticeU.S. Attorney’s OfficeWestern District of Michigan FOR IMMEDIATE RELEASEFriday, September 1, 2023 GRAND RAPIDS, MICHIGAN —U.S. Attorney for the Western District of Michigan Mark Totten announced that Colorado resident Brendon Gagne, 27, was sentenced to serve 24 months in prison for conspiring to smuggle unapproved, misbranded prescription drugs into the United States and…
Ardmore Nurse Pleads Guilty to Tampering with Pain Medication
Department of JusticeU.S. Attorney’s Officeeastern District of Oklahoma FOR IMMEDIATE RELEASETuesday, September 5, 2023 MUSKOGEE, OKLAHOMA – The United States Attorney’s Office for the Eastern District of Oklahoma announced that Rebecca Elaine Holloway, age 32, of Oklahoma City, Oklahoma, entered a guilty plea to an Information charging her with one count of Tampering with Consumer…
WEFUN Inc Issues Voluntary Nationwide Recall of WEFUN Capsules Due to Presence of Undeclared Sildenafil
Summary Company Announcement Date: August 25, 2023 FDA Publish Date: September 05, 2023 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Undeclared drug, Sildenafil Company Name: WEFUN Inc. Brand Name: Brand Name(s) Product Description: Product Description Dietary Supplement with undeclared Sildenafil Company Announcement FOR IMMEDIATE RELEASE – 08/25/2023 – Brooklyn, New York, WEFUN…
Marlex Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Due to Label Mix-Up
Summary Company Announcement Date: August 30, 2023 FDA Publish Date: August 31, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Label Mix-Up Company Name: Marlex Pharmaceuticals, Inc. Brand Name: Brand Name(s) Marlex Pharmaceuticals, Inc. Product Description: Product Description Digoxin Tablets USP, 0.125mg and 0.25mg Company Announcement FOR IMMEDIATE RELEASE – August 30, 2023…
Getinge/Maquet/Datascope Recalls Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) for Gas Loss and Gas Gain Failures
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Names: Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) and Cardiosave Rescue Intra-Aortic Balloon Pump (IABP) Product Codes and Models: Distribution Dates: March 6, 2012 to May 19,…
Getinge/Maquet/Datascope Recalls Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) for Power Failures When Device is Unseated from Cart
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Recalled Product: Cardiosave Hybrid Intra-Aortic Balloon Pump (IABP) and Cardiosave Rescue Intra-Aortic Balloon Pump (IABP) Product Models: Distribution Dates: March 6, 2012 to May 19, 2023 Devices…